Showing results (381-390 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|February 26, 2021
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United StatesClaire L Simons, Daniel Malone, Michael Wang, et al.Journal of Medical Economics|February 12, 2021
Incidence, predictors, and economic burden of circular anastomotic complications in left-sided colorectal reconstructions involving manual circular staplersStephen P Fortin, Stephen S Johnston, Rusha Chaudhuri, et al.Journal of Medical Economics|February 9, 2021
Modeling the economic value of Ceribell Rapid Response EEG in the inpatient hospital settingJohn P Ney, Kapil Gururangan, Josef ParviziJournal of Medical Economics|October 28, 2016
Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysisN Zakiyah, A D I van Asselt, M J PostmaJournal of Medical Economics|December 13, 2016
The impact of medical insurance coverage and molecular monitoring frequency on outcomes in chronic myeloid leukemia: real-world evidence in ChinaGuangying Sheng, Suning Chen, Ri Zhang, et al.Journal of Medical Economics|December 22, 2016
Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipomaXue Song, Zhimei Liu, Katherine Cappell, et al.Journal of Medical Economics|December 24, 2016
The cost-effectiveness of dulaglutide versus liraglutide for the treatment of type 2 diabetes mellitus in Spain in patients with BMI ≥30 kg/m2Tatiana Dilla, Dimitra Alexiou, Ismini Chatzitheofilou, et al.Journal of Medical Economics|October 25, 2016
Cost effectiveness of adding clostridial collagenase ointment to selective debridement in individuals with stage IV pressure ulcersMarissa J Carter, Adrienne M Gilligan, Curtis R Waycaster, et al.Journal of Medical Economics|February 19, 2019
Health state utilities associated with treatment options for acute myeloid leukemia (AML)Louis S Matza, Kristen A Deger, Timothy A Howell, et al.Journal of Medical Economics|March 6, 2019
Migraine burden and costs in France: a nationwide claims database analysis of triptan usersAnne Donnet, Corinne Emery, Samia Aly, et al.Pageof 241